This inventor holds 1 USPTO granted patent. Top assignees: Institut Pasteur Korea, St Pharm Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Sun Hee Kang: Innovator in Antiviral Compounds
Introduction
Sun Hee Kang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His work focuses on creating effective treatments for diseases caused by viral infections, specifically influenza.
Latest Patents
Sun Hee Kang holds 1 patent for his invention titled "Heteroaryl compound, enantiomer, diastereomer or pharmaceutically acceptable salt thereof, and antiviral composition containing same as active ingredient." This patent describes a novel heteroaryl compound that exhibits remarkable antiviral activity against influenza viruses. The compounds are characterized by low cytotoxicity, which minimizes adverse effects on the human body. Consequently, the pharmaceutical composition derived from these compounds can be effectively utilized for the prevention or treatment of influenza virus infections.
Career Highlights
Throughout his career, Sun Hee Kang has worked with prestigious organizations, including Institut Pasteur Korea and St Pharm Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field of virology and pharmaceuticals.
Collaborations
Sun Hee Kang has collaborated with several professionals, including Young Mi Kim and Junghwan Choi. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Sun Hee Kang's innovative work in antiviral compounds highlights his commitment to improving public health through scientific research. His contributions are vital in the ongoing battle against viral infections, particularly influenza.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile